CLDF Podcast
By Chronic Liver Disease Foundation
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Chronic Liver Disease Foundation
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 63
Description
The official podcast channel for the Chronic Liver Disease Foundation.
| Episode | Date |
|---|---|
|
Optimizing Clinical Pathways to Achieve Functional Cure in CHB
|
Jun 03, 2026 |
|
Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines
|
May 12, 2026 |
|
Navigating Non-Adherence and Compliance in Wilson's Disease
|
May 06, 2026 |
|
TIPS Procedure: Identifying Candidates and Minimizing Risk
|
Apr 22, 2026 |
|
Complications of Cirrhosis: The Basics
|
Apr 22, 2026 |
|
What You May Be Missing: Screening For Wilson Disease in Routine Clinical Practice
|
Apr 22, 2026 |
|
Wilson Disease: Therapeutic Landscape & Future Directions
|
Apr 22, 2026 |
|
The Multidisciplinary Team: Your Guide to Cirrhosis and Portal Hypertension Care
|
Apr 22, 2026 |
|
Timing Is Everything: When is TIPS Appropriate?
|
Apr 15, 2026 |
|
Best Practices in Ongoing Monitoring of MASH Patients
|
Apr 02, 2026 |
|
Navigating Treatment Options in 2026
|
Apr 02, 2026 |
|
Management of Portal Hypertension
|
Apr 02, 2026 |
|
How to Monitor Patients With Compensated Cirrhosis
|
Apr 02, 2026 |
|
Monitoring & Follow Up of Patients With CHB
|
Mar 12, 2026 |
|
What Are the Current Strategies for Managing Pruritus in Patients With PBC?
|
Feb 10, 2026 |
|
What Special Considerations Should Be Taken While Managing PBC in Pregnant Patients?
|
Feb 10, 2026 |
|
Pathophysiology and Overview of Hepatitis B
|
Feb 02, 2026 |
|
Patient Centric Care Approaches in CHB
|
Oct 06, 2025 |
|
Patient Centric Care Approaches in PBC
|
Oct 06, 2025 |
|
Education & Engagement for CHB Patients
|
Sep 22, 2025 |
|
Introduction to Understanding Hepatitis B
|
Sep 22, 2025 |
|
Quantitative HBsAg Testing in CHB Patients
|
Sep 22, 2025 |
|
Monitoring and Follow Up of Patients With PBC
|
Sep 11, 2025 |
|
Guideline Implementation for PBC Patients
|
Sep 11, 2025 |
|
Diet and Lifestyle Modifications in PBC: What Can We Recommend to Our Patients?
|
Aug 07, 2025 |
|
The Psychological Impact of PBC: Addressing Mental Health in Our Patients
|
Aug 05, 2025 |
|
How Can We Overcome Barriers to Treatment Adherence in PBC?
|
Jul 31, 2025 |
|
New Therapeutic Options and Management Strategies Symposium Recap
|
Jul 29, 2025 |
|
Managing Complications in PBC: How Do We Improve Patient Quality of Life?
|
Jul 24, 2025 |
|
New Treatment Options for PBC: What’s on the Horizon for Our Patients?
|
Jul 22, 2025 |
|
Physician Insights in Caring For Patients With PBC
|
Jul 02, 2025 |
|
Practical Approaches to PBC Clinical Management
|
Jul 02, 2025 |
|
Symptom Management in PBC Patients
|
Jul 02, 2025 |
|
PBC Patient Quality of Life
|
Jul 02, 2025 |
|
Preventing Clinical Decompensation in Cirrhosis and Portal Hypertension
|
Jun 20, 2025 |
|
Resmetirom: The First FDA-Approved Therapy for MASH
|
May 28, 2025 |
|
What is Resmetirom and How Does it Work to Treat MASH?
|
May 28, 2025 |
|
A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature
|
May 28, 2025 |
|
What is the Clinical Profile of Resmetirom, Including Dosing Schedules
|
May 28, 2025 |
|
Why is it Difficult to Predict Who Will Progress With MASH and How Quickly?
|
May 28, 2025 |
|
Talk About Role & Efficacy in Resmetirom: Elaborate on Response Rate
|
May 28, 2025 |
|
How Does MASH Progress Over Time?
|
May 28, 2025 |
|
Better Understanding of PBC Patients Overall Liver Health and Managing Patients Holistically
|
Apr 04, 2025 |
|
Unable to Differentiate/Identify Between Slow & Fast Progressors - Need to Manage More Aggressively
|
Apr 04, 2025 |
|
Need for Clinicians to Better Understand The "Area Under the Curve" in Non-Response to UDCA
|
Apr 04, 2025 |
|
Biomarkers Beyond ALP to Monitor for Measuring PBC UDCA Response to Therapy and Disease Progression
|
Apr 04, 2025 |
|
Not Responding to UDCA in the First Few Months, Need to Move on to Second-Line Therapy
|
Apr 04, 2025 |
|
Need for Earlier Evaluation of UDCA Response, Need for Earlier Consideration of Second-Line Therapy
|
Apr 04, 2025 |
|
Building a Sense of Urgency for PBC Patient Evaluation/Monitoring
|
Apr 04, 2025 |
|
Importance of Understanding Impact on Disease Outcomes: Progression to Fibrosis and Cirrhosis
|
Apr 04, 2025 |
|
Part 4- Cirrhosis and HE Patient Education
|
Jun 18, 2024 |
|
Part 3- HE Stratification and Surgery
|
Jun 18, 2024 |
|
Part 2- Refractory HE
|
Jun 18, 2024 |
|
Part 1- Initial Diagnosis Counseling of HE Patients
|
Jun 18, 2024 |
|
Key Take Aways-Major Advancements In The Management of MASH with Parvez, Mantry, MD
|
May 22, 2024 |
|
Metabolic-Associated Steatotic Liver Disease: Positioning New and Emerging Therapies with Nancy Reau, MD, Kimberly Brown, MD, and Steven Flamm, MD.
|
May 22, 2024 |
|
Health-Related Quality of Life and Emerging Therapies In PBC
|
May 22, 2024 |
|
CLDF Conversations - Host Nadege Gunn, MD Interview with Sujit Janardhan, MD, PhD
|
May 06, 2024 |
|
CLDF Conversations - Host Nancy Reau, MD with Special Guests Andrew S. DeLemos, MD & Chathur Acharya, MD
|
May 06, 2024 |
|
MASH- What We Don't Know, What We Want to Know
|
May 06, 2024 |
|
Strategies for Educating the APP Community on MASH
|
May 06, 2024 |
|
Using NITs to Identify and Manage MASH Patients
|
May 06, 2024 |
|
Incorporating the Newly Approved Therapy for MASH into Practice
|
May 06, 2024 |